SOX9 and colorectal carcinoma: Consistent with the previous results, immunofluorescence showed that overexpression of SOX9 augmented DNA repair under oxaliplatin treatment in CRC cells, but oeSOX9 RKO cells with loss of MMS22L showed less DNA repair activity than Vector RKO cells (Figures 4A,B).